Article info

Download PDFPDF

Extended report
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

Authors

  1. Correspondence to Professor Arthur Kavanaugh, Division of Rheumatology, Allergy, Immunology, University of California, San Diego, 9500 Gilman Drive, Room A-112, La Jolla,CA 92093-0943, USA; akavanaugh{at}ucsd.edu
View Full Text

Citation

Kavanaugh A, McInnes IB, Mease PJ, et al
Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study

Publication history

  • Accepted October 7, 2012
  • First published November 17, 2012.
Online issue publication 
October 03, 2013

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.